Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12616000629437Phase 3Recruiting
Phase 3, randomised, double-blind trial in adhesive capsulitis (AC) and shoulder tendinopathy comparing Metformin with Placebo (2 arms). Primary endpoint: Proportion of participants with VAS pain score 2 or less out of 10 at 12 months. Started May 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12616000629437.